Basel Medical Group (BMGL) Competitors

$1.20 +0.02 (+1.69%)

As of 09:51 AM Eastern

BMGL vs. TOI, AIRS, DCGO, EUDA, CORBF, XGN, ATPC, SERA, KDLY, and QIPT

Should you be buying Basel Medical Group stock or one of its competitors? The main competitors of Basel Medical Group include Oncology Institute (TOI), AirSculpt Technologies (AIRS), DocGo (DCGO), EUDA Health (EUDA), Global Cord Blood (CORBF), Exagen (XGN), Agape ATP (ATPC), Sera Prognostics (SERA), Kindly MD (KDLY), and Quipt Home Medical (QIPT). These companies are all part of the "healthcare" industry.

Basel Medical Group vs.

Basel Medical Group (NASDAQ:BMGL) and Oncology Institute (NASDAQ:TOI) are both small-cap services companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, profitability, institutional ownership, risk, media sentiment, community ranking, dividends, valuation and earnings.

: 36.9% of Oncology Institute shares are owned by institutional investors. 8.5% of Oncology Institute shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.
: In the previous week, Oncology Institute had 2 more articles in the media than Basel Medical Group. MarketBeat recorded 5 mentions for Oncology Institute and 3 mentions for Basel Medical Group. Basel Medical Group's average media sentiment score of 0.95 beat Oncology Institute's score of 0.13 indicating that Basel Medical Group is being referred to more favorably in the media.
Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Basel Medical Group
1 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Oncology Institute
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
: Oncology Institute has a consensus target price of $7.00, suggesting a potential upside of 133.10%. Given Oncology Institute's stronger consensus rating and higher probable upside, analysts plainly believe Oncology Institute is more favorable than Basel Medical Group.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Basel Medical Group
0 Sell rating(s)
0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
0.00
Oncology Institute
0 Sell rating(s)

0 Hold rating(s)

1 Buy rating(s)

0 Strong Buy rating(s)
3.00
: Basel Medical Group has a net margin of 0.00% compared to Oncology Institute's net margin of -17.63%. Basel Medical Group's return on equity of 0.00% beat Oncology Institute's return on equity.
Company Net Margins Return on Equity Return on Assets
Basel Medical Group N/A N/A N/A
Oncology Institute -17.63% -186.83% -34.58%
: Basel Medical Group has higher earnings, but lower revenue than Oncology Institute.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Basel Medical Group $10.05M 2.20 N/A N/A N/A
Oncology Institute $403.15M 0.56 -$83.07M -$0.70 -4.29
: Oncology Institute received 5 more outperform votes than Basel Medical Group when rated by MarketBeat users.
Company Underperform Outperform
Basel Medical Group N/A N/A
Oncology Institute Outperform Votes
5
71.43%
Underperform Votes
2
28.57%

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Basel Medical Group	1 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Oncology Institute	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Basel Medical Group	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Oncology Institute	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

Company	Net Margins	Return on Equity	Return on Assets
Basel Medical Group	N/A	N/A	N/A
Oncology Institute	-17.63%	-186.83%	-34.58%

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Basel Medical Group	$10.05M	2.20	N/A	N/A	N/A
Oncology Institute	$403.15M	0.56	-$83.07M	-$0.70	-4.29

Company	Underperform	Outperform
Basel Medical Group	N/A	N/A
Oncology Institute	Outperform Votes 5 71.43%	Underperform Votes 2 28.57%

Summary

Oncology Institute beats Basel Medical Group on 8 of the 13 factors compared between the two stocks.

Get Basel Medical Group News Delivered to You Automatically

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

BMGL vs. The Competition

Export to Excel

Metric	Basel Medical Group	Services – Health Industry	Services Sector	NASDAQ Exchange
Market Cap	$22.15M	$16.58M	$2.72B	$8.28B
Dividend Yield	N/A	N/A	0.32%	4.10%
P/E Ratio	N/A	N/A	5.29	19.58
Price / Sales	2.20	2.31	13.63	119.65
Price / Cash	N/A	N/A	N/A	34.62
Price / Book	N/A	N/A	0.21	4.47
Net Income	N/A	-$40,000.00	-$4.34M	$248.22M
7 Day Performance	-49.37%	-7.81%	-5.13%	-1.32%
1 Month Performance	-72.73%	-11.89%	-7.34%	10.73%
1 Year Performance	N/A	N/A	29.22%	8.40%

Basel Medical Group Competitors List

Export to Excel

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
BMGL Basel Medical Group	N/A	$1.20 +1.7%	N/A	N/A	$22.15M	$10.05M	0.00	36	News Coverage
TOI Oncology Institute	2.2391 of 5 stars	$3.00 -1.5%	$7.00 +133.7%	+424.5%	$227.06M	$393.41M	-3.85	660	Insider Trade
AIRS AirSculpt Technologies	0.4304 of 5 stars	$3.65 +2.8%	$3.75 +2.7%	+24.2%	$214.55M	$172.10M	-26.07	240	Gap Up
DCGO DocGo	3.8035 of 5 stars	$1.50 +6.8%	$3.56 +138.1%	-55.5%	$152.47M	$520.50M	5.34	2,920
EUDA EUDA Health	N/A	$3.92 -0.9%	N/A	+57.2%	$145.45M	$4.01M	0.00	2	News Coverage Positive News Gap Down
CORBF Global Cord Blood	N/A	$1.05 -3.7%	N/A	-29.2%	$127.63M	$196.12M	0.00	1,200	Gap Up
XGN Exagen	4.1048 of 5 stars	$5.78 +0.7%	$7.50 +29.8%	+222.5%	$123.11M	$56.72M	-6.15	220
ATPC Agape ATP	0.4386 of 5 stars	$1.97 +31.3%	N/A	-56.6%	$98.46M	$1.32M	-2.70	40	Analyst Upgrade Gap Down
SERA Sera Prognostics	1.4833 of 5 stars	$2.37 -0.8%	N/A	-77.1%	$89.26M	$115,000.00	-2.39	120	Positive News
KDLY Kindly MD	1.0533 of 5 stars	$12.50 -9.8%	N/A	N/A	$72.52M	$2.47M	-15.64	N/A	Gap Up
QIPT Quipt Home Medical	1.691 of 5 stars	$1.41 -7.0%	$4.43 +214.9%	-45.5%	$60.46M	$244.72M	-8.25	800	Analyst Downgrade

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:BMGL) was last updated on 5/23/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Basel Medical Group (BMGL) Competitors

BMGL vs. TOI, AIRS, DCGO, EUDA, CORBF, XGN, ATPC, SERA, KDLY, and QIPT

Basel Medical Group vs.

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

BMGL vs. The Competition

Basel Medical Group Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Basel Medical Group (BMGL) Competitors

BMGL vs. TOI, AIRS, DCGO, EUDA, CORBF, XGN, ATPC, SERA, KDLY, and QIPT

Basel Medical Group vs.

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

BMGL vs. The Competition

Basel Medical Group Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools